Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GPCR compared with ARWR: revenue, margins and what each company keeps, and the suppliers and customers both name
GPCR
Structure Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
ARWR
Arrowhead Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
GPCR
Structure Therapeutics Inc.
vs
ARWR
Arrowhead Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
GPCR: latest quarter not drawable. ARWR: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
GPCR, solid
ARWR, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only GPCR
0
None
Shared
0
No disclosed counterparties: GPCR.
Only ARWR
4
AMGN
Amgen
customer
SRPT
Sarepta Therapeutics
customer
NVS
Novartis Pharma
customer
—
Takeda Pharmaceutical
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
GPCR
Structure Therapeutics Inc.
Change
21.89
▼
−0.22%
· post 22.41
Mkt cap
$4.8B
Revenue
—
Revenue
—
ARWR
Arrowhead Pharmaceuticals, Inc.
Change
60.49
0.00%
· post 59.64
Closed
Oct 30 '26
Mkt cap
$8.5B
Revenue
$75M
Q3 FY26
Revenue
$829M
FY25
vs
Compare
Closed
Oct 30 '26
GPCR
Structure Therapeutics Inc.
vs
ARWR
Arrowhead Pharmaceuticals, Inc.
21.89
▼
−0.22%
post 22.41
Price
60.49
0.00%
post 59.64
$4.8B
Mkt cap
$8.5B
—
Revenue
$75M
Q3 FY26
—
Revenue
$829M
FY25
Change
Change
GPCR
21.89
▼
−0.22%
vs
ARWR
60.49
0.00%
Closed
Oct 30 '26